Significant Ownership of ELI LILLY & Co
- Signature - Title
- /s/ Christopher Anderson - Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
- Location
- Indianapolis, IN
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by ELI LILLY & Co.
Follow Filing Activity
Follow ELI LILLY & Co and return when a new Schedule 13D/G filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
Useful next steps after a schedule filing
Use the page below that answers the next obvious question about this reporting manager or security.
- Latest 13D/G reports to compare this manager with other current ownership disclosures.
- Latest insider ownership reports if you want insider activity alongside the beneficial ownership record.
- Latest 13F portfolio filings for broader institutional context.
- Latest investment quarter holder pages when the next step is security-level holder history.
Significant Ownership of ELI LILLY & Co
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| AKTSQ | Aktis Oncology, Inc. | Common Stock, $0.0001 par value per share | 12% | $63,441 | 6,344,114 | Eli Lilly and Company | 12 Jan 2026 | ||
| IMCR | Immunocore Holdings plc | Ordinary Shares | 0% | 0 | ELI LILLY & Co | 30 Sep 2025 |
Schedules 13D/G Reported by ELI LILLY & Co:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.